In our study, the only relevant clinical risk factor for BM was tumor size, and other clinical factors (i.e., sex, age, smoking history, tumor pathology, EGFR mutations) did not show significance as risk factors regarding BM in the participants. Here, EGFR is linked to neoplasm.